News Details

( 26 Jul 2018)
Sun Pharma. - Board Meeting Intimation for Notice Of Board Meeting For Consideration And Approval Of Unaudited Standalone And

SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2018 ,inter alias, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2018.

In view of the consideration of the above, the window closure for trading by designated persons as per Insider Trading Rules of the Company will be from Friday, August 03, 2018 to Friday, August 17, 20 18 (both days inclusive).